This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Yukihiro Sugita: Innovator in Neurotrophic Protein Research
Introduction
Yukihiro Sugita is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of neurotrophic proteins, particularly through his research and patent work. His innovative approach has implications for neuronal differentiation, neuron survival, and glial inhibition.
Latest Patents
Yukihiro Sugita holds a patent related to the characterization of the neurotrophic protein known as pigment epithelium-derived factor (PEDF). This patent includes nucleic acids encoding PEDF, a truncated version referred to as rPEDF, and equivalent proteins. The patent also covers vectors comprising such nucleic acids, host cells into which these vectors have been introduced, and recombinant methods for producing PEDF and rPEDF. The effects and uses of these variants on neuronal differentiation, neuron survival, and glial inhibition are described in detail.
Career Highlights
Sugita works for the United States of America as represented by the Department of Health. His research has led to advancements in understanding the neurotrophic effects of PEDF and its variants. His work is crucial for developing therapeutic strategies for neurodegenerative diseases.
Collaborations
Yukihiro Sugita has collaborated with notable colleagues such as Takayuki Taniwaki and Gerald J Chader. These collaborations have enhanced the depth and impact of his research in the field of neurotrophic proteins.
Conclusion
Yukihiro Sugita's contributions to neurotrophic protein research through his patent and collaborations highlight his role as an innovator in the field. His work continues to influence advancements in neuroscience and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
